Abstract:Objective Many children were found to have low free carnitine level in blood by tandem mass spectrometry technology.In some of the cases the problems occurred secondary to malnutrition,organic acidemia and other fatty acid oxidation metabolic diseases,and some of cases had primary carnitine deficiency (PCD).In the present article,we discuss the diagnosis of PCD and evaluate the efficacy of carnitine in the treatment of PCD.Method We measured the free carnitine (CO) and acylcarnitine levels in the blood of 270 000 neonates from newborns screening program and 12 000 children with suspected clinical inherited metabolic diseases by tandem mass spectrometry.The mutations of carnitine transporter protein were tested to the children with low CO level and the diagnosis was made.The children with PCD were treated with 100-300 mg/kg of carnitine.Result Seventeen children were diagnosed with PCD,6 from newborn screening program and 11 from clinical patients.Mutations were found in all of them.The average CO level [(2.9 ±2.0) μ mol/L] in patients was lower than the reference value ( 10 μmol/L),along with decreased level of different acylcarnitines.The clinical manifestations were diverse.For the 6 patients from newborn screening,4 were asymptomatic,1 showed hypoglycaemia and 1 showed movement intolerance from 2 years of age. For the 11 clinical patients,8 showed hepatomegaly,7 showed myasthenia,6 showed cardiomyopathy,1 showed chronic abdominal pain,and 1 showed restlessness and learning difficulty.Among these patients,14 cases were treated with carnitine.Their clinical symptoms disappeared 1 to 3 months later.The CO level in the blood rose to normal,with the average from (4.0 ±2.7) μmol/L to (20.6 ± 8.3) μmol/L (P ＜ 0.01 ).However,the level was still lower than the average level of healthy children [( 27.1 ±4.5 ) μmol/L,P ＜0.01].Conclusion Seventeen patients were diagnosed with PCD by the test levels of free carnitine and acylcamitines in blood with tandem mass spectrometry,and gene mutation test.Large dose of carnitine had a good effect in treatment of the PCD patients.

A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene

Identification of LAMA2 Compound Heterozygous Variants: a Case Report

Detection of SLC22A5 gene mutation in a family with primary carnitine deficiency and prenatal diagnosis

Molecular investigation in Chinese patients with primary carnitine deficiency

Biochemical and Genetic Characteristics of 40 Neonates with Carnitine Deficiency.

Clinical, Biochemical, and Molecular Genetic Characteristics of Patients with Primary Carnitine Deficiency Identified by Newborn Screening in Shanghai, China

Analysis of genetic mutations in Chinese patients with systemic primary carnitine deficiency.

[Clinical and genetic analysis of two pedigrees affected with Carnitine-acylcarnitine translocase deficiency due to variant of SLC25A20 gene]

Primary carnitine deficiency: Estimation of prevalence in Chinese population and insights into newborn screening

Clinical characteristics and genetic analysis of six children with carnitine palmitoyltransferase 2 deficiency.

Primary carnitine deficiency in 17 patients: diagnosis, treatment and follow up

Detection of SLC25A13 gene mutation in a family with primary carnitine deficiency and prenatal diagnosis

Screening and Short-Term Follow-Up of Newborns and Mothers with Primary Carnitine Deficiency

Clinical, Pathological and Molecular Genetic Analysis of Pediatric Lipid Storage Myopathy

A case of malonyl coenzyme A decarboxylase deficiency with novel mutations and literature review

Newborn Screening and Genetic Analysis Identify Six Novel Genetic Variants for Primary Carnitine Deficiency in Ningbo Area, China

Screening Primary Carnitine Deficiency in 10 Million Chinese Newborns: a Systematic Review and Meta-Analysis.

A pedigree of a rare Cb1X type X-linked methylmalonic acidemia due to transcriptional co-regulator HCFC1 ;mutation

Progresses of in diagnosis and treatment of primary carnitine deficiency

A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features

Clinical and genetic analysis of a case with atypical ethyl malonate encephalopathy